USA - NASDAQ:STIM - US64131A1051 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to STIM. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-06 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-03-05 | Citizens Capital Markets | Maintains | Market Outperform -> Market Outperform |
| 2025-03-05 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-08-14 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-08-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-08-12 | William Blair | Downgrade | Outperform -> Market Perform |
| 2024-05-14 | William Blair | Upgrade | Market Perform -> Outperform |
| 2024-03-06 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2023-05-10 | JMP Securities | Reiterate | Market Outperform |
| 2023-03-08 | JMP Securities | Reiterate | Market Outperform |
| 2023-03-08 | Canaccord Genuity | Maintains | Buy |
| 2021-10-14 | JMP Securities | Maintains | Market Outperform |
| 2021-10-13 | BTIG | Downgrade | Buy -> Neutral |
9 analysts have analysed STIM and the average price target is 6.63 USD. This implies a price increase of 233.17% is expected in the next year compared to the current price of 1.99.
The consensus rating for NEURONETICS INC (STIM) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering NEURONETICS INC (STIM) is 9.